Compare Lustrum:Renascience Inc.:4889

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Renascience Inc. 4889 Medicals 東証グロース March 1, 2000 2021.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Renascience Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Renascience Inc. Balance Sheet 2023年3月期 Renascience Inc. Balance Sheet 2022年3月期 Renascience Inc. Balance Sheet 2021年3月期 Renascience Inc. Balance Sheet 2020年3月期 Renascience Inc. Balance Sheet 年0月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents
(Percent)
2,212down
(97.3%)down
2,387up
(97.9%)up
1,026up
(96.2%)down
981
(96.9%)

-
Other Current AssetsHelp
(Percent)
55up
(2.4%)up
42up
(1.7%)up
17up
(1.6%)up
7
(0.7%)

-
Tangible Fixed AssetsHelp
(Percent)
4up
(0.2%)up
4up
(0.1%)down
4up
(0.3%)down
3
(0.3%)

-
Intangible Fixed AssetHelp
(Percent)
0
(0.0%)
0
-
13down
(1.2%)down
15
(1.5%)

-
Investments and OthersHelp
(Percent)
3down
(0.1%)down
6down
(0.3%)down
7up
(0.7%)up
6
(0.6%)

-
Total AssetsHelp
(Percent)
2,275
(100%)
2,438
(100%)
1,067
(100%)
1,013
(100%)
-
(100%)
Total Current LiabilitiesHelp
(Percent)
100up
(4.4%)up
38up
(1.6%)down
29up
(2.8%)up
11
(1.1%)

-
Total Long-term LiabilitiesHelp
(Percent)
310up
(13.6%)up
199down
(8.2%)down
476up
(44.6%)up
380
(37.5%)

-
Shareholder's EquityHelp
(Percent)
1,865down
(82.0%)down
2,201up
(90.3%)up
562down
(52.6%)down
622
(61.4%)

-
Total LiabilitiesHelp
(Percent)
2,275
(100%)
2,438
(100%)
1,067
(100%)
1,013
(100%)
-
(100%)

Renascience Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Renascience Inc. Profit and Loss Account 2023年3月期 Renascience Inc. Profit and Loss Account 2022年3月期 Renascience Inc. Profit and Loss Account 2021年3月期 Renascience Inc. Profit and Loss Account 2020年3月期 Renascience Inc. Profit and Loss Account 年0月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales
(Percent)
101
(100%)
139
(100%)
210
(100%)
72
(100%)
-
(100%)
Total Sales
(Percent)
101
(100%)
139
(100%)
210
(100%)
72
(100%)
-
(100%)
Cost of SalesHelp
(Percent)
0down
(0.2%)down
58up
(41.9%)up
30up
(14.3%)down
20
(27.8%)

-
Other Costs and RevenueHelp 436up
(433.7%)up
335up
(240.6%)up
280up
(133.4%)down
236
(327.9%)

-
Total CostsHelp 436 394 310 256 -
Net RevenueHelp 100up
(99.8%)up
81down
(58.1%)down
180up
(85.7%)up
52
(72.2%)

-
Earnings Before TaxHelp -334down
(-332.0%)down
-253down
(-181.6%)down
-100up
(-47.5%)up
-184
(-255.2%)

-
Net IncomeHelp -336down
(-334.0%)down
-254down
(-182.5%)down
-100up
(-47.7%)up
-184
(-255.6%)

-
当期純利益 -336 -254 -100 -184 -

Renascience Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Renascience Inc. Cash Flow Statement 2023年3月期 Renascience Inc. Cash Flow Statement 2022年3月期 Renascience Inc. Cash Flow Statement 2021年3月期 Renascience Inc. Cash Flow Statement 2020年3月期 Renascience Inc. Cash Flow Statement 年0月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
-285down
(-100.0%)down
-230down
(-14.5%)up
-89up
(-65.8%)down
-178
(-31.9%)

-
Investing Cash Flow(ICF)Help
(Percent)
0up
(0.1%)up
-0up
(0.0%)up
-2up
(-1.3%)up
-381
(-68.1%)

-
Financing Cash FlowHelp
(Percent)
110down
(38.8%)down
1,592up
(100.0%)
136down
(100.0%)up
380
(68.0%)

-
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
(0.0%)
0
-
-0
(0.0%)
0
-

-
Net Increase and Decrease in Cash and Cash Equivalentsn -174down
(-61.1%)down
1,361up
(85.5%)up
45up
(32.9%)up
-179
(-32.0%)

-

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Renascience Inc.

Company where related level is highHelp

Fuji Pharma Co.,Ltd.
BrightPath Biotherapeutics Co., Ltd.
Kringle Pharma,Inc.
ONO PHARMACEUTICAL CO.,LTD.
PeptiDream Inc.
MEDICAL & BIOLOGICAL LABORATORIES CO.
KISSEI PHARMACEUTICAL CO.,LTD.
LTT Bio-Pharma Co.,Ltd.
TAISHO PHARMACEUTICAL CO.,LTD.
CanBas Co.,Ltd.